Cutler Group LP Aldeyra Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	BUY	$3.25 - $5.17 $1,625 - $2,585	500 Added 100.0%	1,000 $0
Q4 2021 Jan 18, 2022	SELL	$3.5 - $9.63 $1,050 - $2,889	-300 Reduced 37.5%	500 $0
Q3 2021 Oct 26, 2021	BUY	$7.94 - $11.31 $6,352 - $9,048	800 New	800 $2,000
Q2 2019 Aug 09, 2019	SELL	$6.0 - $9.0 $600 - $900	-100 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$7.14 - $9.85 $57,834 - $79,785	-8,100 Reduced 98.78%	100 $0
Q3 2018 Nov 07, 2018	BUY	$6.8 - $14.35 $55,760 - $117,670	8,200 New	8,200 $4,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.